GRAPHICAL ABSTRACT
![](/cms/asset/c1cea176-e154-4560-aaae-d387eba8417a/gpss_a_1054930_uf0001_c.gif)
Abstract
A series of novel N,N-disubstituted ethyl P-[2-(1H-indol-3-yl)acetyl]phosphoramid-ates were synthesized. All title compounds were characterized by IR, NMR (1H, 13C, 31P) spectra, mass spectra, and C, H, N analysis. The anticancer activity of the title compounds was evaluated in two human cell lines MCF-7 (breast cancer) and HeLa (Cervical cancer) cell lines by the use of the MTT assay, and the IC50 values were determined. The derivatives with substituted piperazines exhibited significant cytotoxicity against the tested cell lines at 5 μM and displayed low IC50 values in the region of 5.8–8.8 μM for MCF-7 cell lines and 14.8–16.4 μM for HeLa cell lines when compared with the standard doxorubicin (5.4 and 14.2 μM).
ACKNOWLEDGMENTS
The authors acknowledge with gratitude the help of Aptus Bio-Sciences Private Limited, Mahabubnagar 509002, Andhra Pradesh, India and Hyderabad Central University, India for providing anticancer activity and spectral data, respectively.